Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional)
National Institutes of Health
At a glance
This funding opportunity is offered by National Institutes of Health. Awards are up to $850,000.
Classification and identifiers
- Solicitation number
- PAR-25-454
- Assistance listing (CFDA)
- 93.398
Amount
$850,000
Who can apply
Other Eligible ApplicantsEligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
About this opportunity
This funding opportunity seeks to support the Comprehensive Partnerships to Advance Cancer Health (CPACH) Program. The CPACH Program develops and maintains comprehensive, long-term, mutually beneficial partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers (CCs). The program aims to achieve a stronger national cancer program and addresses challenges in cancer research, including a focus on advancing research on health drivers that contribute to differences in cancer outcomes across all populations, as well as cancer outreach and engagement.
Related opportunities
- Critical Path Public Private Partnerships Clinical Trials OptionalFood and Drug AdministrationUp to $20.0M
- REACHing Communities (REACH) Consortium (U01) Clinical Trials OptionalFood and Drug AdministrationUp to $3.0M
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)National Institutes of HealthCloses Oct 2026Up to $600K
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)National Institutes of HealthCloses Nov 2026Up to $150K
- Limited Competition: Community-Partnered Nursing Research Centers for Schools and Colleges of Nursing with Limited NIH Funding (P20 Clinical Trial Optional)National Institutes of Health
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)National Institutes of Health